GenLumina develops groundbreaking nanomedicines: silver-DNA packets that, activated by light, destroy cancer cells in a targeted manner. This technique minimizes damage to healthy tissue and paves the way for precision treatment of tumors.
GenLumina develops groundbreaking nanomedicines: silver-DNA packets that, activated by light, destroy cancer cells in a targeted manner. This technique minimizes damage to healthy tissue and paves the way for precision treatment of tumors.
Want to keep up with the latest developments from all the innovators and entrepreneurs within the PLNT Community? Check the latest news.